Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Jun 15, 2016 $3.56 $4.20 $3.47 $4.01 233 676
Jun 14, 2016 $3.46 $3.60 $3.40 $3.48 46 114
Jun 13, 2016 $3.26 $3.51 $3.26 $3.48 47 164
Jun 10, 2016 $3.45 $3.45 $3.25 $3.27 41 352
Jun 09, 2016 $3.57 $3.57 $3.34 $3.40 48 721
Jun 08, 2016 $3.66 $3.71 $3.52 $3.55 30 924
Jun 07, 2016 $3.76 $3.87 $3.60 $3.64 34 443
Jun 06, 2016 $3.55 $3.85 $3.51 $3.75 78 924
Jun 03, 2016 $3.58 $3.66 $3.51 $3.57 16 570
Jun 02, 2016 $3.50 $3.72 $3.50 $3.59 48 948
Jun 01, 2016 $3.31 $3.50 $3.20 $3.43 49 163
May 31, 2016 $3.45 $3.60 $3.28 $3.34 67 684
May 27, 2016 $3.39 $3.50 $3.38 $3.46 14 533
May 26, 2016 $3.41 $3.42 $3.37 $3.37 30 471
May 25, 2016 $3.24 $3.38 $3.22 $3.36 28 932
May 24, 2016 $3.29 $3.29 $3.18 $3.24 54 742
May 23, 2016 $3.25 $3.31 $3.21 $3.25 30 130
May 20, 2016 $3.24 $3.34 $3.15 $3.27 30 327
May 19, 2016 $3.24 $3.27 $3.14 $3.24 35 455
May 18, 2016 $3.24 $3.30 $3.23 $3.23 28 246
May 17, 2016 $3.26 $3.28 $3.20 $3.26 45 748
May 16, 2016 $3.15 $3.30 $3.10 $3.25 70 339
May 13, 2016 $3.26 $3.31 $3.13 $3.13 65 463
May 12, 2016 $3.57 $3.68 $3.24 $3.31 175 240
May 11, 2016 $3.44 $3.63 $3.12 $3.53 143 932
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT